Clinical trialNo phase (not a drug trial)Recruiting
Holistic Acupuncture for Patients With Chemotherapy Induced Nausea
HOL-AKU: Holistic Acupuncture for Patients With Chemotherapy Induced Nausea
- Outcome
- Ongoing
- Phase
- No phase (not a drug trial)
- Status
- Recruiting
- Study type
- Interventional
- Start
- 17 November 2025
- Expected end
- 31 December 2027
- Enrollment
- 90 participants
- Sites
- 1
- Primary outcomes
- Patient reported nausea assessed on the EORTC-15-PAL Scale
- Sponsor type
- Academic / other
- Results posted
- No
- Last update
- 28 May 2026
These fields come from the trial’s registry entry. A summary of its population, design, endpoints and results, each tied to a quote, has not been written for this trial yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.
Try
Source text
Brief summary public domain (ClinicalTrials.gov)
The study explores whether acupuncture as a supplement to conventional antiemetic medicine is superior in reducing the level of chemotherapy induced nausea compared to conventional anitemetic medicine alone. A total of 90 patients experiencing chemotherapy induced nausea will be allocated 1:1 to either acupuncture and antiemetic medicine or antiemetic medicine alone. The level of nausea and other cancer related symptoms will be assessed at baseline and 8 and 22 days after enrollment